Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 14, 2017
Highly selective on-off fluorescence recognition of Fe<sup>3+</sup> based on a coumarin derivative and its application in live-cell imagingSona Warrier, Prashant S KharkarPharmaceutical Patent Analyst|November 7, 2014
Fluorescent probes for biomedical applications (2009-2014)Sona Warrier, Prashant S KharkarFuture Medicinal Chemistry|March 1, 2014
Reverse docking: a powerful tool for drug repositioning and drug rescuePrashant S Kharkar, Sona Warrier, Ram S GaudExpert Opinion on Therapeutic Patents|May 3, 2017
Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015)Prashant S KharkarJournal of Medicinal Chemistry|December 16, 2020
Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future PerspectivesPrashant S KharkarCurrent Topics in Medicinal Chemistry|May 3, 2020
Computational Approaches for the Design of (Mutant-)Selective Tyrosine Kinase Inhibitors: State-of-the-Art and Future ProspectsPrashant S KharkarF1000Research|April 12, 2014
Drugs acting on central nervous system (CNS) targets as leads for non-CNS targetsPrashant S KharkarOrganic & Biomolecular Chemistry|August 22, 2003
A proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug designPrashant S Kharkar, Vithal M KulkarniDrug Development Research|December 6, 2023
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeuticsRameshwar S Cheke, Prashant S KharkarJournal of Enzyme Inhibition and Medicinal Chemistry|May 25, 2018
Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agentsChetan P Shah, Prashant S KharkarPageof 7